Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Ifosfamide × Sarcoma × Clear all

Phase

Phase 2 55 Phase 3 28 Phase NA 12 Phase 1 11 Phase 1/2 10 Phase 2/3 3 Phase EARLY_PHASE1 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 8 Other hematologic neoplasm 5 Sarcoma 1 Dermatologic 1

Conditions

Interventions

Imatinib Mesylate 3 nilotinib 2 Sunitinib 2 Ibandronic Acid 2 Doxorubicin 2 Cyclophosphamide 2 regorafenib 1 pegylated granulocyte colony-stimulating factor 1 nirogacestat 1 avapritinib 1 anlotinib 1 Zoledronic Acid 1 Tranexamic Acid 1 Thiotepa 1 Ritonavir 1 Radiotherapy 1 Pregabalin 1 Oxaliplatin 1 Nevirapine 1 Midazolam 1 Lopinavir 1 Lithium Carbonate 1 Lead 1 Kyphoplasty 1 Indocyanine Green 1 Ifosfamide 1 Hyperbaric Oxygenation 1 Filgrastim 1 Esomeprazole 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03514381 2026-04-14

IPIAP-STM

Institut Claudius Regaud

Phase 4 Completed

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡